Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis (Q34728711)

4 August 2017

1 reference

24 December 2022

1 reference

1 reference

1 reference

Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis (English)

1 reference

Vancomycin-resistant Enterococcus

4 August 2017

1 reference

17 September 2019

1 reference

7 November 2019

1 reference

13 November 2019

1 reference

9 August 2020

1 reference

11 September 2020

1 reference

inferred from abstract

linezolid

1 reference

inferred from abstract

Yu-Chung Chuang

1

0 references

Jann-Tay Wang

object named as

Jann-Tay Wang

series ordinal

2

0 references

Chang Shan-chwen

object named as

Shan-Chwen Chang

series ordinal

4

0 references

Hsin-Yi Lin

series ordinal

3

object named as

Hsin-Yi Lin

1 reference

4 August 2017

1 reference

13 December 2014

12 references

4 August 2017

23 March 2019

22 June 2019

4 August 2019

17 September 2019

7 November 2019

13 November 2019

19 November 2019

20 November 2019

9 August 2020

11 September 2020

24 December 2022

BMC Infectious Diseases

12 references

4 August 2017

23 March 2019

22 June 2019

4 August 2019

17 September 2019

7 November 2019

13 November 2019

19 November 2019

20 November 2019

9 August 2020

11 September 2020

24 December 2022

14

1 reference

4 August 2017

687

1 reference

Creative Commons Attribution 4.0 International

4 August 2017

1 reference

24 December 2022

1 reference

https://scigraph.springernature.com/pub.10.1186/s12879-014-0687-9

0 references

cites work

Difficulties in demonstrating superiority of an antibiotic for multidrug-resistant bacteria in nonrandomized studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Management of multidrug-resistant enterococcal infections

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Optimizing therapy for vancomycin-resistant enterococci (VRE).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

From conference abstract to full paper: differences between data presented in conferences and journals

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Linezolid: the first oxazolidinone antimicrobial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Hematologic effects of linezolid: summary of clinical experience

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

A new system for grading recommendations in evidence based guidelines

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Development of daptomycin for gram-positive infections

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Vancomycin-resistant enterococcal infections

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269951

Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0687-9

Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0687-9

Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0687-9

Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12879-014-0687-9

Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients

21 January 2018

1 reference

12 December 2020

Vancomycin-resistant enterococci

1 reference

12 December 2020

Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium

1 reference

12 December 2020

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock

1 reference

12 December 2020

Therapeutic options for infections due to vancomycin-resistant enterococci

1 reference

12 December 2020

Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan

1 reference

12 December 2020

10.1186/S12879-014-0687-9

Identifiers

DOI

1 reference

PubMed ID

25495779

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference

PubMed ID

25495779